Observational studyThoracic cancer2026

TP53 CpG Site Mutations Predict the Survival of First-Line Chemoimmunotherapy in Advanced Lung Adenocarcinoma.

Lige Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.